Skip to main content

Inflammatory Bowel Disease

In this podcast, Vivian Huang, MSc, MD, speaks about her recent systematic review and meta-analysis that aimed to determine the risk of adverse maternal, placental, and obstetric outcomes in women with inflammatory bowel disease.
Which treatment-related manifestation have you encountered the most that has prompted you to change your therapeutic approach to patients with inflammatory bowel disease (IBD)?
Gastroenterology Consultant
Do you think dietary modifications are necessary in inflammatory bowel disease management? Let us know by taking our quick poll.
In this video, Gastroenterology Consultant Advisory Board Member David Hudesman, MD, talks about how his staff is coping with COVID-19 challenges, as well as how he helps his staff reduce stress and risk of infection.
A new registry database called Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) aims to track novel coronavirus (COVID-19) cases among patients with inflammatory bowel disease (IBD).
Back to Top